MedPath

Atlantic Pharmaceuticals Ltd.

πŸ‡¬πŸ‡§United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:1
Completed:3

Trial Phases

2 Phases

Phase 1:2
Phase 3:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
2 (50.0%)
Phase 3
2 (50.0%)

Phase 1 Food Effect Study for Alicaforsen Tablets

Phase 1
Completed
Conditions
IBD
Interventions
First Posted Date
2018-03-22
Last Posted Date
2018-11-07
Lead Sponsor
Atlantic Pharmaceuticals Ltd
Target Recruit Count
15
Registration Number
NCT03473626
Locations
πŸ‡¬πŸ‡§

Phase 1 unit, Nottingham, United Kingdom

Efficacy of Alicaforsen in Pouchitis Patients Who Have Failed to Respond to at Least One Course of Antibiotics

Phase 3
Completed
Conditions
Pouchitis
Interventions
Drug: Placebo
First Posted Date
2015-08-17
Last Posted Date
2020-02-25
Lead Sponsor
Atlantic Pharmaceuticals Ltd
Target Recruit Count
138
Registration Number
NCT02525523
Locations
πŸ‡ΊπŸ‡Έ

Site Reference ID/Investigator# 1008, La Jolla, California, United States

πŸ‡ΊπŸ‡Έ

Site Reference ID/Investigator # 1005, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Site Reference ID/Investigator#1011, Stanford, California, United States

and more 38 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.